Muhammad Yazid Jalaludin

Liraglutide in Children and Adolescents with Type 2 Diabetes

William V. Tamborlane, Margarita Barrientos‐Pérez, Udi Fainberg et al. · New England Journal of Medicine · 2019 · 347 citations · Full text

Medicine, Endocrinology, Pediatrics +12

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

Kevan C. Herold, Stephen E. Gitelman, Steven M. Willi et al. · Diabetologia · 2012 · 157 citations

Medicine, Endocrinology, Immunology +12

Triglyceride to HDL-C Ratio is Associated with Insulin Resistance in Overweight and Obese Children

Nur Ahmad Kamil Zati Iwani, Muhammad Yazid Jalaludin, Ruziana Mona Wan Mohd Zin et al. · Scientific Reports · 2017 · 139 citations · Full text

Medicine, Child Health, Endocrinology +16

Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial

Claudia K. Fox, Margarita Barrientos‐Pérez, Eric M. Bomberg et al. · New England Journal of Medicine · 2024 · 109 citations

Medicine, Pediatrics, Pharmacology +16

An exploratory study on risk factors for chronic non-communicable diseases among adolescents in Malaysia: overview of the Malaysian Health and Adolescents Longitudinal Research Team study (The MyHeART study)

Majid Abdul Hazreen, Tin Tin Su, Muhammad Yazid Jalaludin et al. · BMC Public Health · 2014 · 85 citations · Full text

Public Health, Chronic Disease Prevention, Health Sciences +17